FDA clears Marconi CT scanner update
The FDA has given 510(k) clearance for Marconi Medical Systems to market its latest version of the Acqsim CT simulation scanner with a larger bore and a larger field-of-view.The Acqsim scanner has an 85-cm bore, compared with 70 cm for earlier
The FDA has given 510(k) clearance for Marconi Medical Systems to market its latest version of the Acqsim CT simulation scanner with a larger bore and a larger field-of-view.
The Acqsim scanner has an 85-cm bore, compared with 70 cm for earlier versions. It also features a 60-cm display field-of-view, up from 48 cm, along with laser positioning lights and oncology-specific scanner protocols and controls.
Marconi says the new scanner simplifies treatment planning for difficult cases such as breast tumors, Hodgkins lymphoma, and large patients. The company said it has more than 50 customers interested in the simulator.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
